Filing Details
- Accession Number:
- 0001209191-15-071273
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-17 20:31:25
- Reporting Period:
- 2015-09-15
- Filing Date:
- 2015-09-17
- Accepted Time:
- 2015-09-17 20:31:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1394319 | Tracon Pharmaceuticals Inc. | TCON | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1590442 | Partnership Limited Investment V3 Super Jafco | Otemachi First Square, West Tower 11F 1-5-1 Otemachi, Chiyoda-Ku Tokyo M0 100-0004 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-09-15 | 17,300 | $11.79 | 1,638,414 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-09-16 | 5,552 | $11.84 | 1,632,862 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-09-17 | 19,492 | $11.76 | 1,613,370 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $11.25 to $12.07. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $11.595 to $12.01. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $11.60 to $11.86. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
